News

Introducing Templeton's First Single Barrel Rye Whiskey

Introducing Templeton's First Single Barrel Rye Whiskey

Templeton Distillery Launches Its First Single Barrel Rye

A milestone release celebrating craftsmanship, community, and authenticity.

Templeton Distillery proudly unveils its inaugural rye whiskey, a Single Barrel release marking a pivotal moment in the brand's evolution. This limited-time-only expression is meticulously distilled, aged, and bottled at cask strength right at the Templeton Distillery.

Born from a vision to craft whiskey in the heart of small-town Iowa, Templeton's evolution to crafting its own distilled whiskey from grain to glass began when the distillery opened its doors nearly eight years ago. Now, that vision reaches its fruition with the first rye barrels that were laid down at the distillery, now produced as the inaugural Single Barrel release - a rye whiskey that captures the individuality of every cask and the spirit of the community that built it.

"We are delighted to introduce Templeton Single Barrel Rye - a whiskey meticulously crafted for our fans and connoisseurs alike," said Shane Fitzharris, Senior Vice President, Global Commercial at Infinium Spirits. "This release embodies our spirit of innovation while honoring our rich heritage, setting a new benchmark for excellence in American whiskey. Each pour offers a rare and remarkable expression of character and craft; no two barrels alike, each with its distinct personality and complexity."

Bottled at cask strength, Templeton Single Barrel offers a bold, warming rye experience - with aromas of spice and oak layered over subtle sweetness. Each sip unfolds with depth and intensity, leading to a rich, lingering finish that reflects the soul of Templeton's small-batch craftsmanship.

Best enjoyed neat, with a splash of water, or in a classic Old Fashioned, Templeton Single Barrel highlights the brand's signature rye character.

Old Fashioned Recipe

- 2 oz Templeton Single Barrel Rye Whiskey
- 0.25 oz Demerara syrup
- 2 dashes Angostura bitters
- Garnish: grapefruit peel

Method

- Add syrup and bitters into a chilled rocks glass.
- Stir until combined.
- Fill a rocks glass with one large ice cube, add Templeton Single Barrel, and gently stir until chilled.
- Express the oil from the grapefruit peel over the glass and use it as a garnish.

Bottled at barrel proof, this release is crafted from a 95% rye, 5% malted barley mash bill and matured in charred new American oak barrels. Templeton Single Barrel is now available for a limited time only at select retailers and online for a suggested price of $49.99.

About Templeton American Whiskey
Templeton American Whiskey is built on a historic legacy of craftsmanship, innovation, and bold flavor. Born in the small town of Templeton, Iowa, our whiskey traces its roots back to the Prohibition era, when local bootleggers perfected a rye whiskey that became legendary. Today, we carry that tradition forward, crafting high-quality American whiskey that embodies perseverance, authenticity, and a commitment to excellence.

With our new distillery in our small hometown, we are continuously refining our craft—melding the skills and time-honored techniques of our local community with modern innovation and state-of-the-art production. Our portfolio includes award-winning expressions such as Templeton Rye 6 Year, Templeton Rye 10 Year, and our first distillate release, Templeton FORTITUDE Bourbon. Every bottle is a testament to the strength of community and masterful blending that define Templeton Whiskey.

More than just a drink, Templeton Whiskey is a symbol of our legacy—crafted for those who appreciate genuine moments, real character, and authentic whiskey. With new releases on the horizon, we remain committed to pushing the boundaries of American whiskey-making while honoring our town's history and the bold spirit that started it all.

About Infinium Spirits
Founded in 2005, Infinium Spirits is a family-owned spirits company based in San Diego, California. Infinium specializes in building and accelerating the growth of its premium and innovative spirits portfolio through unmatched sales, marketing, and distribution expertise. With a footprint in more than 75 countries and a commitment to consumer-driven innovation, Infinium Spirits is reshaping the global spirits industry.

Frequently Asked Questions

What is Templeton’s Single Barrel Rye?

Templeton’s Single Barrel Rye is the brand's inaugural release of rye whiskey, celebrating its evolution from sourcing to crafting its whiskey.

How is Templeton Single Barrel Rye produced?

It is meticulously distilled from 95% rye, aged in charred new American oak barrels, and bottled at cask strength.

What should I pair with Templeton Single Barrel Rye?

This whiskey is best enjoyed neat, with a splash of water, or in classic cocktails like the Old Fashioned.

Where can I purchase Templeton Single Barrel Rye?

It is available at select retailers and online for a limited time, with a suggested retail price of $49.99.

What is the history of Templeton Whiskey?

Templeton Whiskey is rooted in a Prohibition-era legacy, known for its craftsmanship, authenticity, and bold flavors that have evolved over the years.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Bidease Taps Moloco Veteran Dock Kim for Growth Role

Updated Category News Views 7

In the rough-and-tumble world of mobile advertising, cutting through the noise with real results is no easy feat. Yet Bidease finds itself riding high on a wave of growth—200% revenue increase over back-to-back years. That's no small potatoes, and now they're topping it off with a savvy hire: Dock Kim, the former revenue honcho at Moloco, is on deck as the new VP of...

Continue Reading
Unicycive Faces Legal Heat Amid Stock Tumble

Updated Category News Views 2

Unicycive Therapeutics' Rough Ride In this wild market, sometimes even the most seasoned investors get blindsided. Unicycive Therapeutics (NASDAQ: UNC) shareholders are currently caught in a storm with their stock nose-diving by 39.1% on June 30, 2026. It's like being taken to the cleaners without the decency of a warning. Failed Expectations & FDA Blues Here's the...

Continue Reading
Patrick Ta Beauty Adds New Leadership to Expand Growth

Updated Category News Views 2

Angela Simpson and Carolyne Rapp Join the Ranks In the fast-paced world of beauty, where trends shift faster than a day trader’s mood, Patrick Ta Beauty is shaking things up with some heavyweight hires. Angela Simpson steps in as Chief Marketing Officer, and Carolyne Rapp takes the reins as Vice President of Creative. Maybe it’s just me, but when a brand ropes in pros...

Continue Reading
Gala Spotlights Veterans' Mental Health Support

Updated Category News Views 11

Champions for Veterans Honored at Headstrong Gala If you ever wondered who stands in the trenches alongside veterans facing mental health battles, this year's Headstrong Gala offered a crystal-clear answer. Held on October 16 at Pier Sixty in New York City, this shiindig wasn’t just about schmoozing over canapés. It was about celebrating the grit and guts of those...

Continue Reading
DCK Reveals Versatile Battery-Powered Garden Tools in 2026

Updated Category News Views 2

Battery-Powered Revolution in Louisville The treadmill of lawn care just took a high-tech spin with DCK Tools strutting their stuff at Equip Exposition 2026. Unrolled at the Kentucky Exposition Center, the event from October 21 to 23 was brimming with their battery-powered wares that aim to take the grunt out of yard work. Game-Changing Range of Garden Tools DCK's decked...

Continue Reading
Volvo Faces Rough Q3, Plans Strategic Responses

Updated Category News Views 7

Volvo's Bumpy Ride Through Q3 2026 Volvo Cars isn't painting a pretty picture for the third quarter of 2026. Posting an operating income of SEK -3.7 billion and a negative EBIT margin sitting at -5.6%, they're definitely feeling the heat. Market shifts in China and the U.S. are squeezing them, and it shows. Crunching the Numbers Let's break this down. Revenue nose-dived...

Continue Reading
Hyperliquid Reports Q3 2026 Results with Webcast Insights

Updated Category News Views 5

Unlocking Hyperliquid’s Third Quarter Performance It's time to grab your investing gear because Hyperliquid Strategies Inc is ready to spill the beans on their Q3 2026 performance. The digital asset treasury focused on the hyperventilating HYPE token—fined-tuned to serve US and institutional investors—is broadcasting a live webcast on November 5, 2026. Mark your...

Continue Reading
BioLineRx Explores Synergy in Ovarian Cancer Treatment

Updated Category News Views 3

New Hope on the Ovarian Cancer Front Every so often, something comes along and makes you stop and think—could this be the game-changer in the making? Well, what BioLineRx Ltd. (NASDAQ: BLRX) and Hemispherian AS just dropped at the ESMO 2026 feels a bit like that silver lining for folks fighting the uphill battle against homologous recombination (HR)-proficient ovarian...

Continue Reading
Astra Security Tackles PHP2Shell Vulnerabilities Head-On

Updated Category News Views 4

Unlocking the PHP Puzzle Hot off the press, Astra Security's stepping up to the plate with some freebie tools designed to sniff out and stamp out those pesky PHP2Shell vulnerabilities—CVE-2026-109618 and CVE-2026-109619. If you're not familiar, these suckers rate a whopping 9.2 on the CVSS v4.0 scale, and that means they got the potential to let remote code execution...

Continue Reading
Full-Life's FL-020 Shows Promise for Prostate Cancer

Updated Category News Views 4

Breaking New Ground in Prostate Cancer Treatment You know, it’s not every day you stumble across news in the medical field that perks up the ears of investors, but let me tell ya, Full-Life Technologies' latest data drop has certainly caught my attention. If there’s even a smidge of truth in these findings, we might have a game-changer on our hands in the realm of...

Continue Reading

Top 5 Most Recently Viewed Articles

D.C. Bar Celebrates Top Workplace Recognition for 2025

Updated Category News Views 150

D.C. Bar Celebrates Top Workplace Recognition for 2025 The D.C. Bar is thrilled to share that it has earned a spot on the prestigious list of Top Workplaces for 2025, as awarded by the Washington Post. This acknowledgment highlights organizations that excel in employee satisfaction and engagement in the greater Washington, D.C. area. Robert Spagnoletti, the Chief...

Continue Reading
Elsevier Develops Unique AI Evaluation Framework for Healthcare

Updated Category News Views 492

Elsevier Establishes Innovative Evaluation Framework for AI Tools Elsevier, a front-runner in medical information and analytics, has introduced a pioneering evaluation framework aimed at assessing the efficacy and safety of generative AI clinical decision support tools. This significant advancement is a part of Elsevier Health's AI solutions portfolio, including the...

Continue Reading
Ken Paxton's Lawsuit Challenges Tylenol Safety Claims

Updated Category News Views 218

Overview of Legal Action Against Tylenol Texas Attorney General Ken Paxton has taken a bold step by filing a lawsuit against Johnson & Johnson (NYSE: JNJ) and Kenvue Inc (NYSE: KVUE), accusing both companies of misleading pregnant women regarding the safety of Tylenol. Despite extensive evidence hinting at a connection between acetaminophen, the active ingredient in...

Continue Reading
Investors Take Note: Encompass Health Faces Legal Scrutiny Ahead

Updated Category News Views 184

Understanding the Legal Situation Surrounding Encompass Health The Rosen Law Firm, recognized globally for advocating investor rights, has initiated an inquiry into potential claims concerning Encompass Health Corporation (NYSE: EHC). This investigation stems from serious allegations suggesting that the company may have provided materially misleading information to its...

Continue Reading
Myrtle.ai Enhances ML Inference with Microsecond Latencies

Updated Category News Views 126

Myrtle.ai Unveils VOLLO for Ultra-Low Latency Machine Learning Myrtle.ai, a trailblazer in the field of machine learning (ML) acceleration, is making significant strides with its latest development. The company has introduced support for the VOLLO inference accelerator on the NT400D1x series of SmartNICs from Napatech. This innovation is poised to redefine ML inference...

Continue Reading